Silenced p16 gene can drive colorectal cancer progression

Colorectal cancer is the fourth most common and second deadliest cancer. How colorectal cancer develops is not well understood, but a team led by researchers at Baylor College of Medicine reports in the Journal of Experimental & Clinical Cancer Research that silencing the gene p16, even though the DNA itself does not change, can drive colorectal cancer progression in animal models.

Related Keywords

Irvine ,California ,United States ,Ya Cui ,Xiaomin Chen ,Lanjing Zhang ,Jingyi Jessica Li ,Jiejun Shi ,Li Yang ,Emilyb Lawrence ,Sumimasa Arimura ,Yumei Li ,Lanlan Shen ,Los Angeles ,Nan Gao ,Emily Henderson ,Hyun Jung ,Wei Li ,Christy Lee ,Journal Of Experimental Clinical Cancer Research ,University Of California ,Us Department Of Agriculture ,Princeton Medical Center ,Rutgers University ,Baylor College Of Medicine ,National Institutes Of Health ,Baylor College ,Clinical Cancer Research ,Danl Duncan Comprehensive Cancer Center ,Sung Yun Jung ,Yunping Lei ,California Los Angeles ,National Institutes ,Cancer ,Olorectal ,Colorectal Cancer ,Gene ,Animal Model ,Na ,Na Methylation ,Immune Response ,Medicine ,Utation ,Nutrition ,Ediatrics ,Research ,Humor ,